Drug metabolism phase 1 phase 2
"drug metabolism" AND phase
drug metabolism phase I phase II FDA cytochrome P450 conjugation
| Feature | Phase I: Functionalization | Phase II: Conjugation |
|---|---|---|
| Main purpose | Introduces or exposes a functional group | Attaches a hydrophilic endogenous molecule |
| Typical reactions | Oxidation, reduction, hydrolysis | Glucuronidation, sulfation, acetylation, methylation, glutathione conjugation |
| Main enzymes | Mostly cytochrome P450 (CYP) enzymes | Transferase enzymes, e.g., UDP-glucuronosyltransferases |
| Result | Usually slightly more polar; may create an active, inactive, or toxic metabolite | Usually highly water-soluble and pharmacologically inactive |
| Clinical relevance | Major site of enzyme induction, inhibition, and genetic variation | Important in detoxification and drug elimination |